Search - tctmd.com

Displaying 161 - 180 of 864

Sort: Relevancy | Date

Presentation TCT 2024

Cardiogenic Shock and Use of Cangrelor

Presenter: Babar Basir

October 29, 2024

Presentation TCT 2024

TCT 277: Mechanical Circulatory Support in Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Network Meta-Analysis of Randomized Trials and Propensity-Score Matched Studies

Presenter: Adham Ramadan

October 29, 2024

Presentation TCT 2024

TCT 276: Outcomes Among Hospitalized Patients With ST-Elevation Myocardial Infarction-Associated Cardiogenic Shock With Acute Kidney Injury: A United States Population-Based Cohort Study

Presenter: Bruce Adrian Casipit

October 29, 2024

Presentation TCT 2024

TCT 278: Clinical Outcomes of Patients Who Experienced Loss of Pulse Pressure During Treatment With Impella for Acute Myocardial Infarction & Cardiogenic Shock

Presenter: Babar Basir

October 29, 2024

Presentation TCT 2024

TCT 274: Trends and Outcomes of Impella-Supported PCI in NSTEMI Patients With Cardiogenic Shock

Presenter: Kyeeun Park

October 29, 2024

Presentation TCT 2024

TCT 275: Clinical Outcomes in Acute Myocardial Infarction Cardiogenic Shock Patients Supported With Transvalvular Microaxial Pumps

Presenter: Mark Anderson

October 29, 2024

Presentation TCT 2024

TCT 279: Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Patients Undergoing Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock

Presenter: Atsuyuki Watanabe

October 29, 2024

Presentation TCT 2024

TCT 1548: From Brink of the Abyss to Miracle: Haemodynamic Support With Impella For Cardiogenic Shock, Cardiac Arrest and TAVI in a Patient With Severe Aortic Stenosis and Severe LV Dysfunction

Presenter: Darren Walters

October 29, 2024

Presentation TCT 2024

TCT 268: Comparison of In-Hospital Outcomes and Patterns of Mechanical Circulatory Support for Patients With Cardiogenic Shock Transferred for Impella Support vs Those With In-House Support

Presenter: Karnav Modi

October 29, 2024

Presentation TCT 2024

TCT 270: Contemporary Use of Mechanical Circulatory Support for the Treatment of Acute Myocardial Infarction Cardiogenic Shock (AMI-CS): Insights From the BMC2 Registry

Presenter: Eric Cantey

October 29, 2024

Presentation TCT 2024

TCT 272: DANGER Shock Trial Versus Real-World Use of Microaxial Flow Pump in STEMI-Related Cardiogenic Shock

Presenter: Jack Jnani

October 29, 2024

Presentation TCT 2024

TCT 273: DanGer Shock-Like Profile Predicts the Outcome of Patients With ST-Elevation Myocardial Infarction Related Cardiogenic Shock

Presenter: Norman Mangner

October 29, 2024

Presentation TCT 2024

TCT 269: Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis

Presenter: Giuseppe Tarantini

October 29, 2024

Presentation TCT 2024

Results of DanGer Shock: Risks and Benefits of MCS for Cardiogenic Shock Put Into Perspective

Presenter: Jacob Moeller

October 29, 2024

Presentation TCT 2024

Ways in Which DanGer Will and Will Not Influence Clinical Practice in the EU

Presenter: Jose Henriques

October 29, 2024

Presentation TCT 2024

A Mandate to Generate Evidence for the Use of Temporary Support Devices in Decompensated Chronic Heart Failure Shock

Presenter: Jane Wilcox

October 29, 2024

Presentation TCT 2024

Ways in which DanGer Will and Will Not Influence Clinical Practice in the US

Presenter: David Morrow

October 29, 2024

Presentation TCT 2024

TCT 267: Impact of Microaxial Flow Pump on Central Hemodynamics and Use of Vasoactive Drugs During Intensive Care After Infarct-Related Cardiogenic Shock: A Secondary Analysis of the Danger Shock Trial

Presenter: Nanna Louise Junker Udesen

October 29, 2024

Presentation TCT 2024

TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5

Presenter: Shashank Sinha

October 29, 2024

Presentation TCT 2024

TCT 263: Prospective Validation of the MIRACLE2 Score for Early Neurological Stratification After Out-of-Hospital-Cardiac-Arrest: The GLOBAL-MIRACLE Registry

Presenter: Nilesh Pareek

October 29, 2024

Advertisement

Cardiogenic Shock and Use of Cangrelor

TCT 277: Mechanical Circulatory Support in Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Network Meta-Analysis of Randomized Trials and Propensity-Score Matched Studies

TCT 276: Outcomes Among Hospitalized Patients With ST-Elevation Myocardial Infarction-Associated Cardiogenic Shock With Acute Kidney Injury: A United States Population-Based Cohort Study

TCT 278: Clinical Outcomes of Patients Who Experienced Loss of Pulse Pressure During Treatment With Impella for Acute Myocardial Infarction & Cardiogenic Shock

TCT 274: Trends and Outcomes of Impella-Supported PCI in NSTEMI Patients With Cardiogenic Shock

TCT 275: Clinical Outcomes in Acute Myocardial Infarction Cardiogenic Shock Patients Supported With Transvalvular Microaxial Pumps

TCT 279: Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Patients Undergoing Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock

TCT 1548: From Brink of the Abyss to Miracle: Haemodynamic Support With Impella For Cardiogenic Shock, Cardiac Arrest and TAVI in a Patient With Severe Aortic Stenosis and Severe LV Dysfunction

TCT 268: Comparison of In-Hospital Outcomes and Patterns of Mechanical Circulatory Support for Patients With Cardiogenic Shock Transferred for Impella Support vs Those With In-House Support

TCT 270: Contemporary Use of Mechanical Circulatory Support for the Treatment of Acute Myocardial Infarction Cardiogenic Shock (AMI-CS): Insights From the BMC2 Registry

TCT 272: DANGER Shock Trial Versus Real-World Use of Microaxial Flow Pump in STEMI-Related Cardiogenic Shock

TCT 273: DanGer Shock-Like Profile Predicts the Outcome of Patients With ST-Elevation Myocardial Infarction Related Cardiogenic Shock

TCT 269: Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis

Results of DanGer Shock: Risks and Benefits of MCS for Cardiogenic Shock Put Into Perspective

Ways in Which DanGer Will and Will Not Influence Clinical Practice in the EU

A Mandate to Generate Evidence for the Use of Temporary Support Devices in Decompensated Chronic Heart Failure Shock

Ways in which DanGer Will and Will Not Influence Clinical Practice in the US

TCT 267: Impact of Microaxial Flow Pump on Central Hemodynamics and Use of Vasoactive Drugs During Intensive Care After Infarct-Related Cardiogenic Shock: A Secondary Analysis of the Danger Shock Trial

TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5

TCT 263: Prospective Validation of the MIRACLE2 Score for Early Neurological Stratification After Out-of-Hospital-Cardiac-Arrest: The GLOBAL-MIRACLE Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content